首页> 外文期刊>Retina >A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine.
【24h】

A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine.

机译:一种使用羟氯喹筛查患者多焦点超声心动图的新方法。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To evaluate retinal function in patients on hydroxychloroquine using multifocal electroretinography. METHODS: A retrospective chart review was performed for 23 patients (46 eyes) on hydroxychloroquine therapy and referred for multifocal electroretinogram (mfERG) testing. Duration of treatment, daily hydroxychloroquine dose, visual acuity, fundus examination, color vision testing, Amsler grid testing, visual field examination, and fluorescein angiography results were obtained when available. Multifocal electroretinogram response amplitudes were calculated for the central and paracentral regions and compared with previously published normal values. The central and paracentral regions of the mfERG color difference plot, which assigns colors to localized areas of the mfERG based on deviation from normal, were assessed using a novel Color Difference Plot Scoring System which relies on the color pattern observed within each region. RESULTS: Ninety-two regions were assessed for response amplitudes, 31 of which showed a depressed response amplitude. Of the 17 eyes which had at least one region with a depressed response amplitude, clinical examination findings were relatively benign. Color difference plot scoring showed strong agreement with response amplitude, with a Color Difference Plot Scoring System score of 2 or 3 showing 93.55% sensitivity and 60% specificity for a depressed response amplitude. Interrater reliability of the scoring system as measured by Kendall's W coefficient of concordance was 0.6484 (P < 0.00001). CONCLUSION: The mfERG appears to be able to detect decreased retinal function in hydroxychloroquine patients with normal clinical examinations, and may be useful in identifying patients that require close monitoring for the development of clinically relevant toxicity. The Color Difference Plot Scoring System may be used as a tool to aid in the interpretation of results of the mfERG in the clinic setting.
机译:目的:使用多焦点视网膜电图评价羟氯喹患者的视网膜功能。方法:对23例(46眼)羟氯喹治疗患者进行回顾性图表回顾,并进行多焦点视网膜电图(mfERG)测试。治疗时间,每日羟氯喹剂量,视力,眼底检查,色觉检查,Amsler网格检查,视野检查和荧光素血管造影结果均已获得。计算了中央和中央旁区域的多焦点视网膜电图响应幅度,并将其与先前公布的正常值进行比较。使用新颖的色差图评分系统评估mfERG色差图的中心和中央区域,该色基于与正常值的偏差将颜色分配给mfERG的局部区域,该评分系统依赖于在每个区域内观察到的颜色模式。结果:评估了92个区域的响应幅度,其中31个区域显示出较低的响应幅度。在具有至少一个响应幅度降低的区域的17只眼睛中,临床检查结果相对良性。色差图评分与响应幅度高度吻合,色差图评分系统评分为2或3,对降低的响应幅度显示93.55%的灵敏度和60%的特异性。由肯德尔的W一致性系数测得的评分系统的评分者间可靠性为0.6484(P <0.00001)。结论:mfERG似乎能够通过正常的临床检查在羟氯喹患者中检测到视网膜功能的下降,并且对于识别需要密切监测临床相关毒性发展的患者可能有用。色差图评分系统可以用作在临床环境中帮助解释mfERG结果的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号